Business Daily Media

Men's Weekly

.

Eisai: Jyseleca (Filgotinib) for Rheumatoid Arthritis Launches in Japan

  • Written by ACN Newswire - Press Releases

Eisai: Jyseleca (Filgotinib) for Rheumatoid Arthritis Launches in Japan

TOKYO, Nov 18, 2020 - (JCN Newswire) - Gilead Sciences K.K. and Eisai Co., Ltd. today announced that Jyseleca (filgotinib maleate 200 mg and 100 mg tablets), a new once-daily, oral, JAK (Janus kinase) inhibitor that preferentially inhibits JAK1, will be launched in Japan on November 18 for the treatment of rheumatoid arthritis (RA), with prior

Read more //?#

The Future of Ozi.com.au

Ozi.com.au: The New Benchmark in Australian Digital Services In a digital landscape evolving at breakneck speed, Australian businesses are demand...

Brisbane’s brightest recognised: Daniel Mikus and James Rolph win Specialist Services Award at the 2025 Brisbane Young Entrepreneur Awards - again

Young Brisbane entrepreneurs Daniel Mikus and James Rolph, cofounders of MR Group, have been officially crowned winners of the Specialist Services...

Members greenlight merger of Regional Australia Bank and Summerland Bank

Regional Australia Bank and Summerland Bank will proceed with a merger after members approved the move at their Annual General Meetings this week...

DesignStreet marks 27 years with a bold rebrand

In a fast-moving industry defined by continuous disruption, one independent creative agency is proving that longevity and innovation can go hand i...

Deputy partners with SuperAPI to streamline employee onboarding and help get shift-based industries ready for PayDay Super

Deputy, the global people platform for shift-based work, has announced a new partnership with SuperAPI, marking a major enhancement to its HR pro...

KuCoin invests in Australian sponsorships of the ACC, plus a major campaign with golf icon Adam Scott

KuCoin, a leading global crypto platform built on trust, announced the appointment of James Pinch as the Australian Managing Director, the establish...